About Ruth Roberts

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath. A co-founder of ApconiX, Ruth has 25 years of experience in leading roles in drug safety within large pharma. Ruth is also Chair and Director of Drug Discovery at The University of Birmingham, UK and was previously Global Head of Regulatory Safety at AstraZeneca. With over 140 publications in peer-reviewed journals, she is former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and President of the Academy of Toxicological Sciences. Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development.

ApconiX Sponsors PhD Seminar Day Awards

ApconiX Sponsors PhD Seminar Day Awards The Pharmacology and Therapeutics Department of the University of Liverpool held a Postgraduate Seminar Day on January 19th, 2024, at the Radisson Blu on Old Hall Street Liverpool. ApconiX was delighted to sponsor the awards of best PGR Pharmacology Seminar Day Basic Science [...]

By |2024-02-19T16:53:04+00:00February 13th, 2024|Company News, Careers|Comments Off on ApconiX Sponsors PhD Seminar Day Awards

ApconiX Welcomes Heather Brown and Leah Worthington

ApconiX Welcomes Heather Brown and Leah Worthington ApconiX is delighted to welcome Leah Worthington and Heather Brown, recent graduates, who will both be working with us for the next 12 months. ApconiX regularly hosts early career scientists for capability development projects that run up to a year. Heather recently [...]

By |2024-02-19T16:55:52+00:00February 6th, 2024|Company News, Target Safety Assessments, Careers|Comments Off on ApconiX Welcomes Heather Brown and Leah Worthington

What’s been Hapten-ing over the last 88 years?

What’s been Hapten-ing over the last 88 years? Fancy a historic look at the field of drug hypersensitivity? Well, here’s a fairly hefty review paper… Co-authored by the immunopharmacology team at the University of Liverpool (Xiaoli Meng, Paul Thomson, Dean Naisbitt) and Immunotoxicology Lead Sean Hammond from ApconiX, this [...]

By |2024-01-25T10:53:22+00:00January 25th, 2024|Company News, Toxicology|Comments Off on What’s been Hapten-ing over the last 88 years?

Visyon is the ApconiX Charity for 2024

Visyon is the ApconiX Charity for 2024 Visyon is a charity that supports the emotional health of children, young people and their families in the Cheshire East region of the UK where ApconiX is based.  We got off to an early start and was raising money for Visyon in late 2023. So far we've [...]

By |2024-01-25T10:43:47+00:00January 22nd, 2024|Company News|Comments Off on Visyon is the ApconiX Charity for 2024

An Integrated Approach for Early In Vitro Seizure Prediction Utilising hiPSC Neurons and Human Ion Channel Assays

An Integrated Approach for Early In Vitro Seizure Prediction Utilising hiPSC Neurons and Human Ion Channel Assays ApconiX are delighted with our recent publication in Toxicological Sciences where we presented our new data on our integrated approach to detecting seizure.  After 3 years of research, we launched the seizure [...]

By |2024-01-25T10:49:34+00:00September 26th, 2023|Company News, Publications|Comments Off on An Integrated Approach for Early In Vitro Seizure Prediction Utilising hiPSC Neurons and Human Ion Channel Assays

ApconiX Celebrates the Success of Two of Our Project Students

ApconiX Celebrates the Success of Two of Our Project Students ApconiX supervised two final year first degree students from the University of Birmingham this past academic year and caught up with them after their graduation.  Edward Withnall and Tahera Yasmin were both supervised by Dr Sean Hammond, Immunotoxicology Lead.  [...]

By |2023-10-20T10:31:10+01:00August 29th, 2023|Company News, Careers|Comments Off on ApconiX Celebrates the Success of Two of Our Project Students

ApconiX Welcomes Summer Placement Students

ApconiX Welcomes Summer Placement Students ApconiX is delighted to welcome three summer placement students, Josh Wright, Alex Stephenson and Jim Sidaway. Josh Wright Josh has just finished his first year at Nottingham Trent University where he is studying for a Business and Economics degree.  Wanting to learn more about [...]

By |2023-10-20T10:31:29+01:00August 24th, 2023|Company News, Careers|Comments Off on ApconiX Welcomes Summer Placement Students

Drug Safety Forum – Making Safety Part of Drug Design

Making Safety Part of Drug Design ApconiX has organised a free to attend, one day symposium on drug discovery safety at Magdalene College, Cambridge on the 12th of October. Speakers from GSK, SEDA Pharmaceutical Development Services, AstraZeneca, MSD, ApconiX and Newcells Biotech will deliver a broad scope of thought-provoking [...]

By |2023-10-20T10:32:13+01:00August 9th, 2023|Events|Comments Off on Drug Safety Forum – Making Safety Part of Drug Design

ApconiX Is Offering an Industrial Immunotoxicology Research/Development Internship

ApconiX Is Offering an Industrial Immunotoxicology Research/Development Internship The closing date for this job vacancy has passed.  Please visit our Come and Join Us page for current vacancies.  If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to careers@apconix.com [...]

By |2023-10-20T10:33:43+01:00July 25th, 2023|Company News, Target Safety Assessments, Careers|Comments Off on ApconiX Is Offering an Industrial Immunotoxicology Research/Development Internship
Go to Top